Glofitamab in Chinese Patients With R/R DLBCL

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

DLBCL - Diffuse Large B Cell Lymphoma

Interventions

DRUG

Glofitamab

Glofitamab given in standard dosage

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER